Regression of refractory intraocular large B-cell lymphoma with lenalidomide monotherapy

J Clin Oncol. 2011 Jul 10;29(20):e595-7. doi: 10.1200/JCO.2011.34.7252. Epub 2011 Apr 25.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Eye Neoplasms / drug therapy*
  • Eye Neoplasms / pathology
  • Female
  • Humans
  • Lenalidomide
  • Lymphoma, Large B-Cell, Diffuse / drug therapy*
  • Lymphoma, Large B-Cell, Diffuse / pathology
  • Middle Aged
  • Thalidomide / analogs & derivatives*
  • Thalidomide / therapeutic use

Substances

  • Antineoplastic Agents
  • Thalidomide
  • Lenalidomide